We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma.
- Authors
Zinzani, Pier Luigi; Musuraca, Gerardo; Tani, Monica; Stefoni, Vittorio; Marchi, Enrica; Fina, Mariapaola; Pellegrini, Cinzia; Alinari, Lapo; Derenzini, Enrico; de Vivo, Antonio; Sabattini, Elena; Pileri, Stefano; Baccarani, Michele
- Abstract
To determine the antitumor activity of the proteasome inhibitor bortezomib in patients with cutaneous T-cell lymphoma (CTCL) or peripheral T-cell lymphoma unspecified (PTCLU) with isolated skin involvement.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Vol 25, Issue 27, p4293
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2007.11.4207